Seems to me that some hypothetical company, perhaps a company that "specializes in oral sustained and controlled release drug products" just might be able to create a single agonist bead that mimics the plasma concentration characteristics of both an IR and ER product. One could theoretically, albeit in-artfully, refer to such a product as intermediate release.